Prime Medicine (PRME) Stock Sees Significant Increase After Regulatory Go-Ahead
The recent trading session observed a remarkable surge in the stock value of Prime Medicine, Inc. (NASDAQ: PRME), marking a substantial rise of 9.83% to $4.86. This noteworthy uptick in PRME stock price followed the regulatory clearance for a groundbreaking treatment. On Monday, Prime Medicine (PRME) announced that the U.S. Food and Drug Administration (FDA) […]